CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 7 enrolled
Drug / intervention
CESR Prosthetic Foot +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00494143
NCT00494143Phase 3Completed
CompareCT.gov

Metabolic Cost Savings for Transtibial Amputees Walking With the CESR Foot

US Department of Veterans Affairs·interventional·Posted Jun 29, 2007·Updated Jun 9, 2014

In Brief

A Phase 3 clinical trial evaluating CESR Prosthetic Foot, typical prosthetic foot, and 1 other intervention for Transtibial Amputation. Completed, enrolled 7 participants across 1 site.

Detailed Summary

To determine if below-knee amputees will walk with better efficiency wearing a CESR foot which stores energy at heel strike and releases energy releases energy during push-off.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTranstibial Amputation
CountriesUnited States
CollaboratorsUniversity of Michigan

Timeline

Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 29, 2007
Enrollment StartJul 1, 2007
Primary CompletionMay 1, 2009
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 19.0 years ago

Interventions

CESR Prosthetic Footdevice

a novel prosthetic foot that is designed to store energy and release it at a predetermined time in the gait cycle

typical prosthetic footdevice

patients will wear the prosthetic foot that they were prescribed by the care providers in the clinical team

standardized prosthetic footdevice

a standard foot that has had weights applied to match the mass of the CESR foot